RADYUS Trademark

Trademark Overview


On Thursday, November 21, 2019, a trademark application was filed for RADYUS with the United States Patent and Trademark Office. The USPTO has given the RADYUS trademark a serial number of 88702340. The federal status of this trademark filing is REGISTERED as of Tuesday, June 15, 2021. This trademark is owned by Radyus Research, Inc.. The RADYUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research services in the fields of oncology, immunology, infectious diseases, metabolic and cardiovascular diseases, neurodegenerative and neurological diseases, dermatology, and rare diseases; providing medical and scientific research information for others in the fields of oncology, immunology, infectious diseases, metabolic and cardiovascular diseases, neurodegenerative and neurological diseases, dermatology, and rare diseases; providing medical and scientific analysis for others, namely, medical and scientific analysis in the fields of oncology, immunology, infectious diseases, metabolic and cardiovascular diseases, neurodegenerative and neurological diseases, dermatology, and rare diseases; conducting preclinical trials for others; conducting clinical trials for others; pharmaceutical research and development
radyus

General Information


Serial Number88702340
Word MarkRADYUS
Filing DateThursday, November 21, 2019
Status700 - REGISTERED
Status DateTuesday, June 15, 2021
Registration Number6390288
Registration DateTuesday, June 15, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 22, 2020

Trademark Statements


Pseudo MarkRADIUS
Goods and ServicesMedical and scientific research services in the fields of oncology, immunology, infectious diseases, metabolic and cardiovascular diseases, neurodegenerative and neurological diseases, dermatology, and rare diseases; providing medical and scientific research information for others in the fields of oncology, immunology, infectious diseases, metabolic and cardiovascular diseases, neurodegenerative and neurological diseases, dermatology, and rare diseases; providing medical and scientific analysis for others, namely, medical and scientific analysis in the fields of oncology, immunology, infectious diseases, metabolic and cardiovascular diseases, neurodegenerative and neurological diseases, dermatology, and rare diseases; conducting preclinical trials for others; conducting clinical trials for others; pharmaceutical research and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, November 30, 2019
Primary Code042
First Use Anywhere DateMonday, November 4, 2019
First Use In Commerce DateThursday, May 21, 2020

Trademark Owner History


Party NameRadyus Research, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30327

Party NameRadyus Research, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30327

Party NameRadyus Research, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30327

Trademark Events


Event DateEvent Description
Monday, November 25, 2019NEW APPLICATION ENTERED
Saturday, November 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 25, 2020ASSIGNED TO EXAMINER
Tuesday, February 25, 2020NON-FINAL ACTION WRITTEN
Wednesday, July 22, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 22, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 22, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 22, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 22, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 19, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 20, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 25, 2020NON-FINAL ACTION E-MAILED
Tuesday, February 25, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 20, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, August 20, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, August 20, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, August 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 22, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 29, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, April 29, 2021USE AMENDMENT FILED
Wednesday, May 12, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 12, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 12, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 13, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 15, 2021REGISTERED-PRINCIPAL REGISTER
Friday, October 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED